Related Experiment Video
Updated: May 12, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Stem cell therapy for diabetes
Abstract:
Stem cell therapy holds immense promise for the treatment of patients with diabetes mellitus. Research on the ability of human embryonic stem cells to differentiate into islet cells has defined the developmental stages and transcription factors involved in this process. However, the clinical applications of human embryonic stem cells are limited by ethical concerns, as well as the potential for teratoma formation. As a consequence, alternative forms of stem cell therapies, such as induced pluripotent stem cells, umbilical cord stem cells and bone marrow-derived mesenchymal stem cells, have become an area of intense study. Recent advances in stem cell therapy may turn this into a realistic treatment for diabetes in the near future.
Insights
Stem cell therapy offers hope for diabetes mellitus treatment. Research explores alternatives like induced pluripotent stem cells for safer, effective diabetes management strategies.
Area of Science:
- Regenerative Medicine
- Endocrinology
- Cell Biology
Background:
- Diabetes mellitus poses a significant global health challenge.
- Human embryonic stem cells (hESCs) show potential for differentiating into insulin-producing islet cells.
- Clinical use of hESCs is hindered by ethical issues and teratoma risk.
Purpose of the Study:
- To review the current state of stem cell therapy for diabetes mellitus.
- To explore alternative stem cell sources beyond hESCs.
- To assess the future potential of stem cell-based treatments for diabetes.
Main Methods:
- Review of existing research on stem cell differentiation for diabetes.
- Analysis of developmental stages and transcription factors in islet cell formation.
- Evaluation of alternative stem cell types: induced pluripotent stem cells (iPSCs), umbilical cord stem cells (UCSCs), and bone marrow-derived mesenchymal stem cells (BM-MSCs).
Main Results:
- Understanding of hESC differentiation pathways into islet cells has advanced.
- Ethical concerns and safety (teratoma formation) limit hESC clinical application.
- iPSCs, UCSCs, and BM-MSCs are under intense investigation as viable alternatives.
Conclusions:
- Stem cell research is pivotal for developing novel diabetes mellitus treatments.
- Alternative stem cell sources show promise for overcoming hESC limitations.
- Advancements suggest stem cell therapy could become a realistic future treatment for diabetes.
Related Concept Videos
iPS Cell Differentiation
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Renewal without Stem Cells
However, failure of such a system...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
